Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

New Delhi: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang ...

In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...